|
pA2 online
© Copyright 2004 The British Pharmacological Society
|
028P
University of Newcastle
Winter Meeting December 2004
|
Activation of GQ/11 and GIl-3 proteins by M1 and M3 muscarinic acetylcholine (mACh) receptors: evidence for agonist-specific receptor conformations
Mark R. Dowling1,2 Steven J. Charlton2, Stefan R. Nahorski1, R.A. John Challiss1. 1Dept. of Cell Physiology & Pharmacology, University of Leicester, LE1 9HN, U.K. and 2Respiratory Disease Area, Novartis Institute for Biomedical Research, Horsham, West Sussex, RH12 5AB, U.K. |
Print abstract
Search PubMed for:
Dowling MR
Charlton SJ
Nahorski SR
Challiss RAJ |
The intrinsic activity of agonists to activate M1 and M3 mACh receptors stably expressed in CHO cells was assessed using two [35S]-GTPγS binding methodologies. The total [35S]-GTPγS binding assay measures the global activation of the cellular G protein population, however, through the use of pertussis toxin (PTx), to prevent receptor-mediated activation of Gi-like G subunits, inferences about the subclasses of G proteins activated can be made. Agonist-G protein activation profiles were further investigated using an antibody-capture technique (Akam et al., 2001), which permits the potency or intrinsic activity of G q/11 and G il-3 subunit activation in to be assessed.
Concentration-response curves constructed for total [35S]-GTPγS binding stimulated by methacholine (MCh) in CHO-m1 membranes were biphasic comprising high- and low-affinity components (pEC50s high, 6.23 ± 0.28; low, 4.33 ± 0.05). Pilocarpine failed to cause a significant increase in total [35S]-GTPγS binding. Following pre-treatment of CHO cells with PTx (100 ng ml-1, 24 h), monophasic increases in [35S]-GTPγS binding stimulated by agonist were observed; with the EC50 correlating with the high affinity binding seen in control CHO-m1 membranes (pEC50, 6.26 ± 0.06). Immunoprecipitation of G q/11 following [35S]-GTPγS binding yielded a similar pEC50 estimate (6.21 ± 0.13) for the MCh-stimulated response, supporting the hypothesis that the M1 mACh receptor is efficiently couples to G q/11 . The improved sensitivity of the antibody-capture method revealed that pilocarpine robustly stimulated G q/11 -[35S]-GTPγS binding (pEC50, 6.00 ± 0.17). Assessment of G il-3 -[35S]-GTPγS binding revealed that only the most efficacious agonists could elicit responses above basal, with pilocarpine ineffective. Thus, agonist activation of the M1 mACh receptor appears to follow a ‘strength-of-signal’ model, where agonists activate G q/11 proteins most effectively, only high efficacy agonists active the relatively poorly-coupled G il-3 proteins.
Total [35S]-GTPγS binding concentration-response curves constructed for agonist-mediated responses in CHO-m3 membranes were shallow, but could not reproducibly be better fitted to a two-site model. Following PTx treatment, maximal agonist-mediated total [35S]-GTPγS binding responses were reduced indicating again that a heterogeneous population of G proteins is activated, but that the potency differences for PTx-sensitive and -insensitive G proteins is too small to allow their EC50s to be determined. In agreement, the antibody capture method revealed that a subset of mACh receptor agonists could stimulate robust [35S]-GTPγS binding to both G q/11 and Gil-3 proteins. Although pilocarpine did not stimulate a significant increase in [35S]-GTPγS-G q/11 binding it did increase [35S]-GTPγS-G il-3 binding to approx. 50% of the response evoked by MCh. Therefore, with respect to the M3 mACh receptor, our data provides some evidence for agonist-specific conformations with different G subunit activation profiles.
Akam, E.C. et al. (2001) Br. J. Pharmacol., 132, 950-958. |